China Nuclear Energy Technology Corporation Limited (HKG:0611)
0.4850
0.00 (0.00%)
Aug 1, 2025, 4:08 PM HKT
Inozyme Pharma Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 831.87 | 1,612 | 887.99 | 603.93 | 325.43 | Upgrade |
Short-Term Investments | 39.92 | 5.72 | 5.89 | 9.58 | 23.72 | Upgrade |
Cash & Short-Term Investments | 871.79 | 1,618 | 893.88 | 613.51 | 349.14 | Upgrade |
Cash Growth | -46.12% | 81.03% | 45.70% | 75.72% | -18.14% | Upgrade |
Accounts Receivable | 1,678 | 1,668 | 2,140 | 2,650 | 2,288 | Upgrade |
Other Receivables | 352.53 | 273.69 | 115.32 | 205.87 | 250.92 | Upgrade |
Receivables | 2,035 | 2,046 | 2,469 | 2,987 | 2,625 | Upgrade |
Inventory | - | - | - | - | 148.28 | Upgrade |
Prepaid Expenses | 393.92 | 344.44 | 744.28 | 328.43 | 22.34 | Upgrade |
Other Current Assets | 119.75 | 339.46 | 1,149 | 403.74 | 462.92 | Upgrade |
Total Current Assets | 3,420 | 4,348 | 5,256 | 4,333 | 3,608 | Upgrade |
Property, Plant & Equipment | 6,489 | 5,513 | 2,906 | 1,889 | 2,064 | Upgrade |
Long-Term Investments | 51.65 | 41.61 | 32.54 | 28.95 | 136.33 | Upgrade |
Long-Term Accounts Receivable | 242.07 | 217.94 | 13.5 | 116.2 | 201.33 | Upgrade |
Long-Term Deferred Tax Assets | 0.07 | - | - | - | - | Upgrade |
Other Long-Term Assets | 113.94 | 234.83 | 98.87 | 124.84 | 99.26 | Upgrade |
Total Assets | 10,323 | 10,365 | 8,332 | 6,504 | 6,124 | Upgrade |
Accounts Payable | 891.2 | 1,383 | 1,353 | 2,160 | 1,933 | Upgrade |
Accrued Expenses | 37.67 | 38.14 | 27.85 | 24.47 | 21.91 | Upgrade |
Short-Term Debt | 1,688 | 1,511 | 1,965 | 815.05 | 845.27 | Upgrade |
Current Portion of Long-Term Debt | 410.08 | 362.02 | 376.5 | 502.89 | 514.47 | Upgrade |
Current Portion of Leases | 17.3 | 20.8 | 13.21 | 4.11 | 4.6 | Upgrade |
Current Income Taxes Payable | 9.83 | 11.52 | 13.72 | 12.35 | 4.75 | Upgrade |
Current Unearned Revenue | 183.92 | 213.36 | 543.96 | 93.53 | 71.35 | Upgrade |
Other Current Liabilities | 106.82 | 60.01 | 277.02 | 221.96 | 190.92 | Upgrade |
Total Current Liabilities | 3,345 | 3,599 | 4,570 | 3,834 | 3,586 | Upgrade |
Long-Term Debt | 4,929 | 4,879 | 2,114 | 1,624 | 1,583 | Upgrade |
Long-Term Leases | 337.75 | 277.01 | 149.28 | 4.69 | 1.5 | Upgrade |
Long-Term Deferred Tax Liabilities | 0.08 | 1.63 | - | - | 4.79 | Upgrade |
Total Liabilities | 8,612 | 8,757 | 6,834 | 5,463 | 5,175 | Upgrade |
Common Stock | 162.34 | 162.34 | 163.82 | 106.97 | 110.57 | Upgrade |
Additional Paid-In Capital | 412.5 | 412.5 | 367.17 | 1,244 | 1,286 | Upgrade |
Retained Earnings | 1,189 | 1,074 | 1,014 | -385.65 | -487.78 | Upgrade |
Comprehensive Income & Other | -90.19 | -73.97 | -76.4 | 40.36 | 23.18 | Upgrade |
Total Common Equity | 1,673 | 1,575 | 1,468 | 1,006 | 932.01 | Upgrade |
Minority Interest | 38.02 | 32.25 | 29.5 | 34.95 | 16.82 | Upgrade |
Shareholders' Equity | 1,711 | 1,608 | 1,498 | 1,041 | 948.83 | Upgrade |
Total Liabilities & Equity | 10,323 | 10,365 | 8,332 | 6,504 | 6,124 | Upgrade |
Total Debt | 7,383 | 7,050 | 4,618 | 2,951 | 2,949 | Upgrade |
Net Cash (Debt) | -6,511 | -5,432 | -3,724 | -2,338 | -2,600 | Upgrade |
Net Cash Per Share | -3.52 | -2.93 | -2.24 | -1.78 | -1.98 | Upgrade |
Filing Date Shares Outstanding | 1,852 | 1,852 | 1,852 | 1,313 | 1,313 | Upgrade |
Total Common Shares Outstanding | 1,852 | 1,852 | 1,852 | 1,313 | 1,313 | Upgrade |
Working Capital | 75.04 | 748.35 | 685.57 | 499.02 | 21.67 | Upgrade |
Book Value Per Share | 0.90 | 0.85 | 0.79 | 0.77 | 0.71 | Upgrade |
Tangible Book Value | 1,673 | 1,575 | 1,468 | 1,006 | 932.01 | Upgrade |
Tangible Book Value Per Share | 0.90 | 0.85 | 0.79 | 0.77 | 0.71 | Upgrade |
Buildings | - | - | - | - | 36.18 | Upgrade |
Machinery | 6,797 | 4,199 | 3,135 | 2,204 | 1,930 | Upgrade |
Construction In Progress | 444.65 | 1,795 | 109.07 | 35.48 | 333.16 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.